Uji Aktivitas Antiplatelet dan Trombolitik Perasan Daging Buah Nanas (Ananas comosus L.) Secara In Vitro

Martina Kurnia Rohmah, Djelang Zainuddin Fickria, Herni Setyawatia

Abstract


ABSTRAK

Penyakit aterotrombosis merupakan salah satu penyebab serangan jantung dan stroke yang bersumber dari adanya sumbatan berupa thrombus pada pembuluh dari arteri. Penyebab munculnya thrombus dapat diakibatkan oleh berbagai faktor diantaranya faktor genetik, kondisi mikrovaskular darah, serta gangguan hemostasis yang menyebabkan hiperkoagulasi. Buah nanas merupakan salah satu bahan alam yang secara empiris dipercaya dapat mengencerkan darah. Penelitian ini bertujuan untuk mengetahui aktivitas antiplatelet dan trombolitik buah nanas secara in vitro. Penelitian yang dilakukan merupakan penelitian eksperimental dengan kontrol negatif menggunakan placebo, kontrol positif menggunakan obat (aspirin dan nattokinase), serta variasi konsentrasi perasan daging buah nanas 25%, 50% dan 100%. Berdasarkan One Way Anova diketahui terdapat perbedaan yang bermakna antara aktivitas antiplatelet dan trombolitik dari 5 perlakuan (p=0,000). Berdasarkan analisis regresi diketahui bahwa perasan daging buah nanas berpengaruh signifikan sebagai antiplatelet dan trombolitik (p=0,000). Sebagai antiplatelet, perasan buah nanas 25%, 50% dan 100% mampu menghambat agregasi platelet sebesar 1,06%. 1,23% dan 1,53%. Sebagai trombolitik, perasan buah nanas dengan konsentrasi 25%, 50% dan 100% mampu melisiskan bekuan sebesar 34,41%, 42,02%, dan 51,27%.

 

Kata kunci : Nanas; Hemostasis; Thrombus; Antiplatelet; Trombolitik.


ABSTRACT

Atherothrombosis is one of the causes of heart attacks and strokes which comes from a blockage in the form of a thrombus in the vessel from the artery. The cause of the appearance of a thrombus can be caused by various factors including genetic factors, blood microvascular conditions, and hemostatic disorders that cause hypercoagulation. Pineapple fruit is one of the natural ingredients which is empirically believed to thin the blood. This study aims to determine the in vitro antiplatelet and thrombolytic activity of pineapple. The research conducted was an experimental study with negative control using placebo, positive control using drugs (aspirin and nattokinase), and variations in the concentration of pineapple flesh juice of 25%, 50% and 100%. Based on One Way Anova, it was found that there were significant differences between the antiplatelet and thrombolytic activities of 5 treatments (p = 0.000). Based on the regression analysis, it was found that pineapple pulp had a significant effect as an antiplatelet and thrombolytic (p = 0.000). As an anti-platelet agent, pineapple flesh juice 25%, 50%, and 100% were able to inhibit platelet aggregation by 1.06%. 1.23% and 1.53%. As a thrombolytic, pineapple flesh juice of 25%, 50%, and 100% were able to lyse clots of 34.41%, 42.02%, and 51.27%.

 

Keywords : Pineapple; Hemostasis; Thrombus; Antiplatelet; Thrombolytic.

 


Keywords


Pineapple; Hemostasis; Thrombus; Antiplatelet; Thrombolytic.

Full Text:

PDF

References


Asada, Y., Yamashita, A., Sato, Y., & Hatakeyama, K. (2020). Pathophysiology of atherothrombosis: Mechanisms of thrombus formation on disrupted atherosclerotic plaques. Pathology International, 70(6), 309-322.

Majithia, A., & Bhatt, D. L. (2019). Novel antiplatelet therapies for atherothrombotic diseases. Arteriosclerosis, thrombosis, and vascular biology, 39(4), 546-557.

Hanson, E. (2009). The hemostatic pathway in ischemic stroke. Journal of Thrombosis and Haemostasis, 7(12), 2147-49.

World Health Organization (WHO). (2018). On world heart day WHO calls for accelerated action to prevent the world’s leading global killer. The global cardiovascular disease (CVD) crisis.

World Health Organization. (2014). Noncommunicable diseases country profiles 2014.

Catricala, S., Torti, M., & Ricevuti, G. (2012). Alzheimer disease and platelets: how’s that relevant. Immunity & Ageing, 9(1), 1-11.

Ghoshal, K., & Bhattacharyya, M. (2014). Overview of platelet physiology: its hemostatic and nonhemostatic role in disease pathogenesis. The Scientific World Journal, 2014.

Lutz, J., Menke, J., Sollinger, D., Schinzel, H., & Thürmel, K. (2014). Haemostasis in chronic kidney disease. Nephrology Dialysis Transplantation, 29(1), 29-40.

Porter, Malcolm. (2020). Clinical Hematology: A Case-Based Approach. Hayley Medical. ISBN: ‎978-1632418883.

Guyatt, G. H., Akl, E. A., Crowther, M., Schünemann, H. J., Gutterman, D. D., & Lewis, S. Z. (2012). Introduction to the ninth edition: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines. Chest, 141(2), 48S-52S.

Wardrop, D., & Keeling, D. (2008). The story of the discovery of heparin and warfarin. British journal of haematology, 141(6), 757-763.

Edwards, Z., & Nagalli, S. (2020). Streptokinase.

Chen, H., McGowan, E. M., Ren, N., Lal, S., Nassif, N., Shad-Kaneez, F., ... & Lin, Y. (2018). Nattokinase: a promising alternative in prevention and treatment of cardiovascular diseases. Biomarker insights, 13, 1177271918785130.

Kim, K., & Park, K. I. (2019). A review of antiplatelet activity of traditional medicinal herbs on integrative medicine studies. Evidence-Based Complementary and Alternative Medicine, 2019.

Lamponi, S. (2021). Bioactive Natural Compounds with Antiplatelet and Anticoagulant Activity and Their Potential Role in the Treatment of Thrombotic Disorders. Life, 11(10), 1095.

Chen, C., Yang, F. Q., Zhang, Q., Wang, F. Q., Hu, Y. J., & Xia, Z. N. (2015). Natural products for antithrombosis. Evidence-Based Complementary and Alternative Medicine, 2015.

Weng, Y., Yao, J., Sparks, S., & Wang, K. Y. (2017). Nattokinase: an oral antithrombotic agent for the prevention of cardiovascular disease. International journal of molecular sciences, 18(3), 523.

Badar, S., Azarkan, M., Mekkawy, A. H., Akhter, J., Pillai, K., El Mahyaoui, R., ... & Morris, D. L. (2021). Comparison of proteolytic, cytotoxic and anticoagulant properties of chromatographically fractionated bromelain to un-fractionated bromelain. American Journal of Translational Research, 13(5), 4309.

Pavan, R., Jain, S., & Kumar, A. (2012). Properties and therapeutic application of bromelain: a review. Biotechnology research international, 2012.

Chakraborty, A. J., Mitra, S., Tallei, T. E., Tareq, A. M., Nainu, F., Cicia, D., ... & Capasso, R. (2021). Bromelain a potential bioactive compound: a comprehensive overview from a pharmacological perspective. Life, 11(4), 317.

Limjuco, R. P., Catalan, M. P., & Aquino, F. C. (2014). Anticoagulant Activity of Pineapple (Ananas comosus) Extract on Human Blood Samples. IAMURE International Journal of Science and Clinical Laboratory, 6(1), 1-1.

Rakasiwi, M. (2013). Efek Antiagregasi Platelet Ekstrak Etanol Buah Nanas (Ananas comusus Merr) pada Mencit Putih Jantan.

Nurhayati, D., Sundara, Y., & Merdekawati, F. (2020). ISOLASI BROMELIN DARI BUAH NANAS (Ananas comosus L. Merr) DENGAN GARAM DAPUR. Jurnal Riset Kesehatan Poltekkes Depkes Bandung, 12(2), 348-355.

Murniati, Endyah. Sang Nanas Bersisik Manis di Lidah. (2012). Surabaya: Surabaya Intellectual Club. ISBN: 9799415748.

Hanani, E. (2015). Analisis Fitokimia. Penerbit Buku Kedokteran EGC: Jakarta.

Maurer, H. R. (2001). Bromelain: biochemistry, pharmacology and medical use. Cellular and Molecular Life Sciences CMLS, 58(9), 1234-1245.

Rohmah, M. K. (2020). Uji Aktivitas Antiplatelet, Antikoagulan dan Trombolitik Alkaloid Total Daun Pepaya (Carica papaya L) secara in Vitro. Jurnal Sains Farmasi & Klinis, 7(2), 1-20.

Chakraborty, A. J., Mitra, S., Tallei, T. E., Tareq, A. M., Nainu, F., Cicia, D., ... & Capasso, R. (2021). Bromelain a potential bioactive compound: a comprehensive overview from a pharmacological perspective. Life, 11(4), 317.

Pavan, R., Jain, S., & Kumar, A. (2012). Properties and therapeutic application of bromelain: a review. Biotechnology research international, 2012.

Fuentes, E., Guzmán, L., Alarcón, M., Moore, R., & Palomo, I. (2014). Thrombolytic/fibrinolytic mechanism of natural products. Fibrinolysis Thrombolysis, 107-121.

Nofianti, K. A., & Ekowati, J. (2019). O-Hydroxycinnamic derivatives as prospective anti-platelet candidates: In silico pharmacokinetic screening and evaluation of their binding sites on COX-1 and P2Y12 receptors. Journal of Basic and Clinical Physiology and Pharmacology, 30(6).

Saad, W. M. M., Ridwan, R., Lasim, N. S. M., Rapi, N. L. M., & Salim, F. (2019). Determination and Quantification of p Coumaric Acid in Pineapples (Ananas comosus) Extracts using Gradient Mode RP-HPLC. Pharmacognosy Research, 11(1).




DOI: https://doi.org/10.31764/lf.v3i2.8330

Refbacks

  • There are currently no refbacks.


EDITORIAL OFFICE: